Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Clinica Baviera ( (ES:CBAV) ) just unveiled an announcement.
Aier Eye International (Europe) and Vito Gestión Patrimonial are exploring the sale of up to 8% of Clínica Baviera’s share capital through an accelerated bookbuilt offering, targeting qualified investors. Alantra Equities has been appointed to manage the transaction, which will not provide proceeds to the company, and the sellers have agreed to a lock-up period post-transaction.
More about Clinica Baviera
YTD Price Performance: 11.95%
Average Trading Volume: 17
Technical Sentiment Signal: Strong Sell
Current Market Cap: €578.8M
See more insights into CBAV stock on TipRanks’ Stock Analysis page.